ResMed Officer Michael J. Rider Proposes Sale of $102K in Common Stock Under Rule 10b5-1
RESMED INC
Subscribe to track RMD
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
=== SEC FORM 144 FILING ===
Company: RESMED INC (RMD)
Insider: Michael J. Rider (Officer)
Action: Proposed Sale
Shares: 400
Value: $102,000.00 (~$255.00/share)
Date: 2026-10-23
Plan: Rule 10b5-1 (Adopted 2026-02-20)
Impact: Low
Comprehensive Analysis
Executive Summary
On October 23, 2026, Michael J. Rider, an Officer of ResMed Inc. (NYSE: RMD), filed Form 144 with the SEC indicating a planned sale of 400 shares of common stock. The aggregate market value of the proposed transaction is $102,000.00, implying a share price of approximately $255.00.
Transaction Details
- Security: Common Stock
- Shares Proposed for Sale: 400
- Market Value: $102,000.00
- Origin of Shares: Acquired on November 11, 2024, via restricted stock vesting as part of equity compensation.
- Broker: Fidelity Brokerage Services LLC
- Trading Plan: The proposed sale is executed pursuant to a Rule 10b5-1 trading arrangement adopted on February 20, 2026.
Market Impact & Context
With 144,252,306 shares outstanding, this proposed disposition accounts for less than 0.0003% of the company's total equity float. Furthermore, because the sale was scheduled under a pre-established Rule 10b5-1 trading plan adopted eight months earlier, this transaction represents routine executive liquidity rather than a sentiment-driven signal. The trading significance is assessed as Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.